These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 26284810

  • 1. LC3B, a Protein That Serves as an Autophagic Marker, Modulates Angiotensin II-induced Myocardial Hypertrophy.
    Huang J, Pan W, Ou D, Dai W, Lin Y, Chen Y, Chen X.
    J Cardiovasc Pharmacol; 2015 Dec; 66(6):576-83. PubMed ID: 26284810
    [Abstract] [Full Text] [Related]

  • 2. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
    Huang J, Sun W, Huang H, Ye J, Pan W, Zhong Y, Cheng C, You X, Liu B, Xiong L, Liu S.
    PLoS One; 2014 Dec; 9(4):e94382. PubMed ID: 24728149
    [Abstract] [Full Text] [Related]

  • 3. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L, Meng W, Ding J, Cheng M.
    Biochem Biophys Res Commun; 2016 Apr 29; 473(2):455-61. PubMed ID: 26970306
    [Abstract] [Full Text] [Related]

  • 4. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL, Lv JB, Gao L.
    Eur Rev Med Pharmacol Sci; 2017 Dec 29; 21(23):5462-5470. PubMed ID: 29243791
    [Abstract] [Full Text] [Related]

  • 5. Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
    Wang HN, Li JL, Xu T, Yao HQ, Chen GH, Hu J.
    Mol Med Rep; 2020 Aug 29; 22(2):1342-1350. PubMed ID: 32468001
    [Abstract] [Full Text] [Related]

  • 6. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
    Lin L, Liu X, Xu J, Weng L, Ren J, Ge J, Zou Y.
    J Cell Mol Med; 2016 Jan 29; 20(1):48-57. PubMed ID: 26515045
    [Abstract] [Full Text] [Related]

  • 7. Downregulated endogenous sulfur dioxide/aspartate aminotransferase pathway is involved in angiotensin II-stimulated cardiomyocyte autophagy and myocardial hypertrophy in mice.
    Chen Q, Zhang L, Chen S, Huang Y, Li K, Yu X, Wu H, Tian X, Zhang C, Tang C, Du J, Jin H.
    Int J Cardiol; 2016 Dec 15; 225():392-401. PubMed ID: 27770734
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy.
    Porrello ER, D'Amore A, Curl CL, Allen AM, Harrap SB, Thomas WG, Delbridge LM.
    Hypertension; 2009 Jun 15; 53(6):1032-40. PubMed ID: 19433781
    [Abstract] [Full Text] [Related]

  • 9. Mst1 knockout enhances cardiomyocyte autophagic flux to alleviate angiotensin II-induced cardiac injury independent of angiotensin II receptors.
    Cheng Z, Zhang M, Hu J, Lin J, Feng X, Wang S, Wang T, Gao E, Wang H, Sun D.
    J Mol Cell Cardiol; 2018 Dec 15; 125():117-128. PubMed ID: 30193956
    [Abstract] [Full Text] [Related]

  • 10. High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.
    Lin L, Liu X, Xu J, Weng L, Ren J, Ge J, Zou Y.
    J Cell Mol Med; 2015 Aug 15; 19(8):1929-38. PubMed ID: 25946687
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.
    Clin Exp Pharmacol Physiol; 2009 Mar 15; 36(3):312-8. PubMed ID: 18986329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX, Liang QS, He XX, Zhan CY.
    Zhongguo Zhong Yao Za Zhi; 2008 Apr 15; 33(8):936-9. PubMed ID: 18619357
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.
    Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874
    [Abstract] [Full Text] [Related]

  • 16. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy.
    Sun B, Huo R, Sheng Y, Li Y, Xie X, Chen C, Liu HB, Li N, Li CB, Guo WT, Zhu JX, Yang BF, Dong DL.
    Hypertension; 2013 Feb 29; 61(2):352-60. PubMed ID: 23248151
    [Abstract] [Full Text] [Related]

  • 17. Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate.
    Zhou D, Liang Q, He X, Zhan C.
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct 29; 28(5):531-4. PubMed ID: 18846332
    [Abstract] [Full Text] [Related]

  • 18. [Effect of NOS and PTEN on cardiomyocyte hypertrophy induced by angiotensin II].
    Wu Y, Hu YE.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb 29; 21(1):41-5. PubMed ID: 21166162
    [Abstract] [Full Text] [Related]

  • 19. Isosorbide dinitrate inhibits mechanical stress-induced cardiac hypertrophy and autophagy through downregulation of angiotensin II type 1 receptor.
    Lin L, Xu J, Ye Y, Ge J, Zou Y, Liu X.
    J Cardiovasc Pharmacol; 2015 Jan 29; 65(1):1-7. PubMed ID: 24887682
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y, Wan L, Bu L, Zhao D, Dong D, Huang T, Cheng Z, Shen B.
    Cell Physiol Biochem; 2013 Jan 29; 31(6):997-1008. PubMed ID: 23860036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.